According to our (Global Info Research) latest study, the global Ophthalmic Perfluoropropane Gas (C3F8) market size was valued at US$ 81.29 million in 2025 and is forecast to a readjusted size of US$ 115 million by 2032 with a CAGR of 5.1% during review period.
In 2025, global Ophthalmic Perfluoropropane Gas (C3F8) production reached approximately 160 k units, with an average global market price of around US$495 per unit. Ophthalmic perfluoropropane gas (C3F8) is a colorless, odorless, non-toxic inert gas, chemically stable, insoluble in water, belongs to Class III medical devices, product specifications are usually 15ml. It is mainly used in vitreo-retinal detachment surgery, as a filling gas material in the eye, by absorbing nitrogen and oxygen in the surrounding tissue and expanding, creating a supporting effect on the retina, promoting its reduction and healing. The gas plays an important role in eye surgery, which can improve the surgical cure rate, reduce surgical risks and complications, simplify the surgical process, and reduce the workload of doctors.
Ophthalmic perfluoropropane gas is an essential intraocular tamponade material in vitreoretinal surgery, with market demand directly linked to the global burden of ophthalmic diseases. Globally, population aging, rising myopia prevalence, and the spread of chronic eye diseases such as diabetic retinopathy collectively drive stable clinical demand for long-acting intraocular filling gases. The widespread adoption of minimally invasive vitrectomy has further increased the clinical usage frequency of this product, and the standardization of surgical techniques has promoted its penetration in medical institutions at different levels.
The production of this product has high technical barriers, with strict requirements for gas purity, impurity control, and sterile processing. Major global markets classify it as a high-risk medical device and implement strict supervision. Long product registration cycles and high clinical verification requirements constitute significant market entry barriers. Meanwhile, the production of fluorine-containing gases is constrained by global environmental protection policies, and raw material supply and capacity layout need to comply with national greenhouse gas emission control requirements, which pose higher challenges to supply chain stability and flexibility.
This report is a detailed and comprehensive analysis for global Ophthalmic Perfluoropropane Gas (C3F8) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by End-user. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Ophthalmic Perfluoropropane Gas (C3F8) market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Ophthalmic Perfluoropropane Gas (C3F8) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Ophthalmic Perfluoropropane Gas (C3F8) market size and forecasts, by Type and by End-user, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Ophthalmic Perfluoropropane Gas (C3F8) market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Ophthalmic Perfluoropropane Gas (C3F8)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Ophthalmic Perfluoropropane Gas (C3F8) market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Alcon, Alchimia, Scott Medical, DORC (ZEISS), Pharmpur, BVI Medical, Fluoron GmbH, Micromed, Shanghai Jesvis Medical Technology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Ophthalmic Perfluoropropane Gas (C3F8) market is split by Type and by End-user. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by End-user in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Pure C3F8
Gas Mixture
Market segment by Specification
30 ml/unit
40 ml/unit
Others
Market segment by Application
Retinal Detachment Repair
Macular Hole Surgery
Others
Market segment by End-user
Hospital
Ophthalmology Clinic
Major players covered
Alcon
Alchimia
Scott Medical
DORC (ZEISS)
Pharmpur
BVI Medical
Fluoron GmbH
Micromed
Shanghai Jesvis Medical Technology
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Ophthalmic Perfluoropropane Gas (C3F8) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Ophthalmic Perfluoropropane Gas (C3F8), with price, sales quantity, revenue, and global market share of Ophthalmic Perfluoropropane Gas (C3F8) from 2021 to 2026.
Chapter 3, the Ophthalmic Perfluoropropane Gas (C3F8) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ophthalmic Perfluoropropane Gas (C3F8) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by End-user, with sales market share and growth rate by Type, by End-user, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Ophthalmic Perfluoropropane Gas (C3F8) market forecast, by regions, by Type, and by End-user, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Ophthalmic Perfluoropropane Gas (C3F8).
Chapter 14 and 15, to describe Ophthalmic Perfluoropropane Gas (C3F8) sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Ophthalmic Perfluoropropane Gas (C3F8). Industry analysis & Market Report on Ophthalmic Perfluoropropane Gas (C3F8) is a syndicated market report, published as Global Ophthalmic Perfluoropropane Gas (C3F8) Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Ophthalmic Perfluoropropane Gas (C3F8) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.